Literatur
Alexander JH, Reynolds HR, Stebbins AL et al (2007) Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 297:1657–1666
Hochman JS, Sleeper LA, Webb JG et al (2006) Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295:2511–2515
Janssens U (2006) Kardiogener Schock nach Myokardinfarkt. Internist 47:383–388
Katz JN, Stebbins AL, Alexander JH et al (2009) Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J 158:680–687
Marenzi G, Moltrasio M, Assanelli E et al (2007) Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 153:755–762
Torgersen C, Schmittinger CA, Wagner S et al (2009) Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study. Crit Care 13:R157
Trzeciak S, Jones AE, Kilgannon JH et al (2009) Significance of arterial hypotension after resuscitation from cardiac arrest. Crit Care Med 37:2895–2903
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Janssens, U., Graf, J. Sterblichkeit bei Patienten mit refraktärem kardiogenem Schock. Intensivmed 47, 286–288 (2010). https://doi.org/10.1007/s00390-009-0149-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00390-009-0149-6